The use of tumor necrosis factor inhibitors in pregnancy: What is the evidence? - 17/09/14
Doi : 10.1016/j.jaad.2014.04.078
Dario Nicolas Kivelevitch, MD, Caitriona Ryan, MD, Alan Menter, MD ⁎ 
Baylor University Medical Center, Dallas, Texas
∗Correspondence to: Alan Menter, MD, Baylor University Medical Center, 3900 Junius St, Suite 125, Dallas, TX 75246
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| Disclosure: Dr Menter has been on the advisory boards of AbbVie, Allergan, Amgen, Boehringer Ingelheim, Genentech, Janssen Biotech Inc, LEO Pharma, and Pfizer; been a consultant for AbbVie, Allergan, Amgen, Convoy Therapeutics Inc, Eli-Lilly, Janssen Biotech Inc, LEO Pharma, Novartis, Pfizer, Syntrix, Wyeth, and XenoPort; been an investigator for AbbVie, Allergan, Amgen, ApoPharma, Boehringer Ingelheim, Celgene, Convoy Therapeutics Inc, Eli-Lilly, Genentech, Janssen Biotech Inc, LEO Pharma, Merck, Novartis, Pfizer, Symbio/Maruho, Syntrix, and Wyeth; been a speaker for AbbVie, Amgen, Janssen Biotech Inc, LEO Pharma, and Wyeth; received grants from AbbVie, Allergan, Amgen, ApoPharma, Boehringer Ingelheim, Celgene, Convoy Therapeutics Inc, Genentech, Janssen Biotech Inc, LEO Pharma, Merck, Pfizer, Symbio/Maruho, and Syntrix; and received honoraria from AbbVie, Allergan, Amgen, Boehringer Ingelheim, Convoy Therapeutics Inc, Eli-Lilly, Genentech, Janssen Biotech Inc, LEO Pharma, Novartis, Pfizer, Syntrix, Wyeth, and XenoPort. Dr Ryan has been on the advisory board and received honoraria from AbbVie and Pfizer. Dr Kivelevitch has been a speaker and received honoraria from AbbVie. |
© 2014
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 71 - N° 4
P. 829-831 - octobre 2014 Retour au numéro
Article précédent
- Comments on “Diet and psoriasis, part I: Impact of weight loss interventions”
- Simone Cazzaniga, Andrea Conti, Luigi Naldi, Psoriasis Emilia Romagna Study Group
- Tumor necrosis factor-alfa inhibitors in pregnancy: To prescribe, or not to prescribe, that is the question
- Jenny E. Murase, Daniel C. Butler
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?